Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...

Multipotency and Niche of Bulge Stem Cell

Multipotency and Niche of Bulge Stem Cell

A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Green extraction of non-starch polysaccharides from millet using a deep eutectic solvent: structural elucidation and structure-activity relationship of their inhibition of α-glucosidase.

Food chemistry·2026

Same author

Metabolic Modulation of Type 2 Diabetes Mellitus by 1-Deoxynojirimycin: A Multifaceted Approach.

Antioxidants (Basel, Switzerland)·2026

Same author

Bioactivity and prebiotic potential of insoluble dietary fiber from discarded Chinese cabbage outer leaves and the metabolomic dynamics of bound polyphenols during alkaline extraction, in vitro gastrointestinal digestion and colonic fermentation.

Food research international (Ottawa, Ont.)·2026

Same author

Detection of the characteristic magnetic signal of paclitaxel and its application in the inhibition of glioma cells.

Fundamental research·2026

Same author

Bidirectional dual-anchoring buried interface regulates crystallization kinetics of perovskite prepared using two-step method for stable and efficient photovoltaics.

Journal of colloid and interface science·2026

Same author

Tailoring a simplified and steady-state kombucha consortium for newly-formulated kiwifruit beverage production: Impacts on untargeted/targeted metabolites, antioxidant capacities and flavor profiles.

Food research international (Ottawa, Ont.)·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Brain tumor stem cells: view from cell proliferation.

Yu Yao¹, Xuqun Tang, Shiqi Li

¹Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. yu_yao02@hotmail.com

Surgical Neurology

|March 3, 2009

Summary

This summary is machine-generated.

Brain tumor-initiating cells (BTICs) are found in human brain tumors and can self-renew and differentiate. Their proliferation status is crucial for tumor growth, with CD133(+) cells showing higher proliferation than CD133(-) cells.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

Area of Science:

Neuroscience
Oncology
Stem Cell Biology

Background:

Brain tumor-initiating cells (BTICs) are a subpopulation within brain tumors with stem-like properties.
These cells are capable of self-renewal, differentiation into various neural lineages, and recapitulating tumor heterogeneity.
Understanding BTIC proliferation is key to comprehending tumor initiation and progression.

Purpose of the Study:

To summarize evidence for BTICs in human brain tumors.
To emphasize the significance of BTIC proliferative status in tumorigenesis.
To compare proliferation between BTICs and normal neural stem cells (NSCs).

Main Methods:

Review of existing literature on BTICs and their proliferation.
Analysis of data comparing proliferation indices of CD133(+) and CD133(-) cell-initiated glioblastomas.
Comparative review of proliferation between BTICs and normal NSCs.

Main Results:

CD133(+) cell-initiated glioblastomas exhibit a higher proliferation index compared to CD133(-) cell-induced glioblastomas.
BTICs demonstrate distinct proliferative characteristics compared to normal NSCs.
Preliminary evidence suggests higher proliferative capacity in BTICs from malignant tumors versus stem/progenitor cells in benign tumors.

Conclusions:

BTICs are a critical component of brain tumors, with their proliferative status influencing malignancy.
The CD133 marker may correlate with increased proliferation in glioblastoma.
Further research into BTIC proliferation is essential for developing targeted therapies.